James Kuo

James Kuo

Founder bei TRYP THERAPEUTICS INC.

Vermögen: 146 760 $ am 31.03.2024

58 Jahre
Health Technology
Finance
Consumer Services

Profil

James S.
Kuo
was the founder of Windtree Therapeutics, Inc. (founded in 1992) and BioMicro Systems, Inc. (founded in 2003), where he held the titles of President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of Tryp Therapeutics, Inc. (founded in 2019) and currently serves as a Director.
Dr. Kuo is also the founder of Monarch Labs, Inc. Dr. Kuo's current jobs include Chairman & Chief Executive Officer at ApoLife, Inc. (since 2012), Chief Executive Officer at Return Health, Inc., Non-Executive Chairman at MSK Pharma LLC, Independent Director at Pharnext SA (starting in 2022), Managing Director at Athena Bioventures, Inc. (since 2007), and Vice President-Research & Development at Silo Pharma, Inc. (starting in 2022).
His former jobs include Chief Executive Officer & IR Contact at FIT Biotech Oy (2016-2018), Chairman & Chief Executive Officer at Cysteine Pharma, Inc. (2006-2007), Chief Executive Officer at OncoTracker, Inc. (2018-2019), Chairman & Chief Executive Officer at KMRB Acquisition Corp.
II, Non-Executive Chairman at Soligenix, Inc. (2004-2009), Chairman at ImmunoPrecise Antibodies Ltd.
(2016-2023), Associate Director-Corporate Licensing at Pfizer Inc. (1995-1997), Managing Director-Venture Analysis at HealthCare Ventures LLC, Director at Cordex Pharma, Inc. (2007-2010), Director at Theriva Biologics, Inc. (2007-2012), and Vice President-Business Development at Myriad Genetics, Inc. (1998-2000).
Dr. Kuo's education includes an undergraduate degree from Haverford College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
Dr. Kuo is also the founder of Monarch Labs, Inc...

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
09.01.2024 6 000 000 ( 6,22% ) 108 000 $ 31.03.2024
17.03.2023 25 500 ( 0,10% ) 38 760 $ 31.03.2024

Aktive Positionen von James Kuo

UnternehmenPositionBeginn
TRYP THERAPEUTICS INC. Founder -
PHARNEXT SCA Director/Board Member 16.06.2022
SILO PHARMA, INC. Chief Tech/Sci/R&D Officer 01.09.2022
Chief Executive Officer -
Corporate Officer/Principal 01.01.2007
Chief Executive Officer 27.09.2012
MSK Pharma LLC Chairman 11.04.2011
Founder -
Alle aktiven Positionen von James Kuo

Ehemalige bekannte Positionen von James Kuo

UnternehmenPositionEnde
IMMUNOPRECISE ANTIBODIES LTD. Chairman 09.11.2023
░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von James Kuo im Detail an

Ausbildung von James Kuo

Haverford College Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
University of Pennsylvania Medical Center Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von James Kuo im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen9
SOLIGENIX, INC.

Health Technology

PFIZER, INC.

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

MYRIAD GENETICS, INC.

Health Technology

SILO PHARMA, INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

PHARNEXT SCA

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

TRYP THERAPEUTICS INC.

Health Technology

Private Unternehmen12

Health Technology

Finance

Health Technology

Process Industries

Health Technology

Commercial Services

Cysteine Pharma, Inc.

MSK Pharma LLC

Finance

Finance

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an